ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,031,000 | +73.9% | 170,980 | +3.8% | 0.00% | – |
| Q3 2019 | $593,000 | +34.2% | 164,707 | -0.1% | 0.00% | – |
| Q2 2019 | $442,000 | +47.3% | 164,879 | +62.7% | 0.00% | – |
| Q1 2019 | $300,000 | +488.2% | 101,328 | +209.8% | 0.00% | – |
| Q4 2018 | $51,000 | -88.2% | 32,709 | -72.1% | 0.00% | – |
| Q3 2018 | $432,000 | +195.9% | 117,403 | +127.4% | 0.00% | – |
| Q2 2018 | $146,000 | -39.4% | 51,629 | -20.9% | 0.00% | – |
| Q1 2018 | $241,000 | +82.6% | 65,298 | +40.9% | 0.00% | – |
| Q4 2017 | $132,000 | -64.1% | 46,351 | -43.5% | 0.00% | – |
| Q3 2017 | $368,000 | +19.1% | 81,969 | +21.6% | 0.00% | – |
| Q2 2017 | $309,000 | -21.8% | 67,415 | -28.0% | 0.00% | – |
| Q1 2017 | $395,000 | -34.8% | 93,678 | -36.2% | 0.00% | – |
| Q4 2016 | $606,000 | -36.3% | 146,721 | +25.1% | 0.00% | -100.0% |
| Q3 2016 | $951,000 | +244.6% | 117,301 | +231.4% | 0.00% | – |
| Q2 2016 | $276,000 | -56.8% | 35,400 | -61.2% | 0.00% | -100.0% |
| Q1 2016 | $639,000 | -63.3% | 91,240 | -47.6% | 0.00% | -66.7% |
| Q4 2015 | $1,741,000 | +42.5% | 174,116 | -14.5% | 0.00% | +200.0% |
| Q3 2015 | $1,222,000 | -59.8% | 203,668 | -46.4% | 0.00% | -75.0% |
| Q2 2015 | $3,038,000 | +19.4% | 379,729 | +34.3% | 0.00% | +33.3% |
| Q1 2015 | $2,544,000 | -70.0% | 282,773 | -59.9% | 0.00% | -62.5% |
| Q4 2014 | $8,466,000 | +37.8% | 705,548 | +3.4% | 0.01% | +14.3% |
| Q3 2014 | $6,143,000 | +147.4% | 682,390 | +92.5% | 0.01% | +133.3% |
| Q2 2014 | $2,483,000 | +453.0% | 354,572 | +136.7% | 0.00% | – |
| Q1 2014 | $449,000 | -37.3% | 149,822 | -37.3% | 0.00% | – |
| Q4 2013 | $716,000 | -44.8% | 238,805 | -44.7% | 0.00% | -100.0% |
| Q3 2013 | $1,296,000 | -52.3% | 431,968 | +30.0% | 0.00% | -33.3% |
| Q2 2013 | $2,716,000 | – | 332,218 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |